Dose- and Time-Dependent Effects of Oleate on Mitochondrial Fusion/Fission Proteins and Cell Viability in HepG2 Cells: Comparison with Palmitate Effects

Int J Mol Sci. 2021 Sep 10;22(18):9812. doi: 10.3390/ijms22189812.

Abstract

Mitochondrial impairments in dynamic behavior (fusion/fission balance) associated with mitochondrial dysfunction play a key role in cell lipotoxicity and lipid-induced metabolic diseases. The present work aimed to evaluate dose- and time-dependent effects of the monounsaturated fatty acid oleate on mitochondrial fusion/fission proteins in comparison with the saturated fatty acid palmitate in hepatic cells. To this end, HepG-2 cells were treated with 0, 10 μM, 50 μM, 100 μM, 250 μM or 500 μM of either oleate or palmitate for 8 or 24 h. Cell viability and lipid accumulation were evaluated to assess lipotoxicity. Mitochondrial markers of fusion (mitofusin 2, MFN2) and fission (dynamin-related protein 1, DRP1) processes were evaluated by Western blot analysis. After 8 h, the highest dose of oleate induced a decrease in DRP1 content without changes in MFN2 content in association with cell viability maintenance, whereas palmitate induced a decrease in cell viability associated with a decrease mainly in MFN2 content. After 24 h, oleate induced MFN2 increase, whereas palmitate induced DRP1 increase associated with a higher decrease in cell viability with high doses compared to oleate. This finding could be useful to understand the role of mitochondria in the protective effects of oleate as a bioactive compound.

Keywords: DRP1; MFN2; cellular adaptation; hepatocytes; lipotoxicity; mitochondrial dynamics; monounsaturated fatty acids; saturated fatty acids.

MeSH terms

  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Dynamins / genetics*
  • Fatty Acids, Monounsaturated / pharmacology
  • GTP Phosphohydrolases / genetics*
  • Gene Expression Regulation / drug effects
  • Hep G2 Cells
  • Humans
  • Lipid Metabolism / drug effects
  • Lipids / toxicity
  • Metabolic Diseases / etiology
  • Metabolic Diseases / genetics*
  • Metabolic Diseases / metabolism
  • Metabolic Diseases / pathology
  • Mitochondria / drug effects
  • Mitochondria / genetics
  • Mitochondria / pathology
  • Mitochondrial Dynamics / drug effects*
  • Mitochondrial Dynamics / genetics
  • Mitochondrial Proteins / genetics*
  • Oleic Acid / metabolism*
  • Oleic Acid / pharmacology
  • Palmitates / metabolism
  • Palmitates / pharmacology

Substances

  • Fatty Acids, Monounsaturated
  • Lipids
  • Mitochondrial Proteins
  • Palmitates
  • Oleic Acid
  • GTP Phosphohydrolases
  • MFN2 protein, human
  • DNM1L protein, human
  • Dynamins